In addition to Kasumi-1, we selected OCI-AML3 as a second cell line which harbors a common, AML typical gene mutation in the DNMT3a gene and features a pronounced hypomethylation phenotype13. The gene discussed is DNMT3A; the disease is acute myeloid leukemia.